LONDON, Jan. 15, 2018 -- A new report from Meticulous Research™, titled as ‘Cardiac Pacemaker Devices Market – Global Opportunity Analysis and Industry Forecast (2017-2022)’, cites the global cardiac pacemaker devices market to reach USD 4,629.3 Million by 2022, growing at a CAGR of 3.3% during the forecast period.
“The global cardiac pacemaker devices market is majorly driven by increasing incidence & prevalence of chronic cardiovascular diseases and technological advancements in the area of implantable cardiac pacemakers. In addition, emerging markets and increasing awareness of healthcare further provides a great opportunity for various stakeholders in this market. However, increase in reported cases of cardiac pacemaker malfunctioning & related product recalls restricts the growth of the market to some extent,” mentions Meticulous Research™.
The report also states that, on the basis of end-user, hospitals held the largest share of cardiac pacemaker devices market due to a large pool of patients visiting hospitals and clinics across the globe for diagnosis & treatment of healthcare concerns including cardiovascular diseases.
Request Sample Report: https://www.meticulousresearch.com/request-sample-report/?cp_id=3568
North America (mainly U.S and Canada) currently have the largest share of the cardiac pacemaker devices market, “due to increasing incidence of cardiovascular diseases with rising greying population and increasing burden of hypertension; well-established healthcare system & distribution channel; higher spending on healthcare; and presence of leading players in the market.”
The key players in this market are Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Lepu Medical Technology Co Ltd (China), Medico, S.p.A (Italy), Osypka Medical GmbH (Germany), Shree Pacetronix Ltd (India), and Cook Medical Group (U.S.).
Scope of the Report:
Market by Product:
- Cardiac pacemakers
- Implantable cardiac pacemakers
-- Single chamber cardiac pacemakers
-- Dual-chamber cardiac pacemakers
- External pacemakers - Pacing leads
- Pacing analyzers
Market by End-user:
- Hospitals
- Ambulatory surgery centers
- Others
Market by Geography:
- North America
- U.S.
- Canada - Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe - Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific - Rest of World
- Latin America
- Middle East & Africa
Enquiry Before Buying- https://www.meticulousresearch.com/enquire-before-buying/?cp_id=3568
Contact Info:
Viren Shrivastava
Email: [email protected]
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Washington Post Publisher Will Lewis Steps Down After Layoffs
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



